COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 1027: Articles 10261-10270  | Next

Reliably Assessing Duration of Protection for COVID-19 Vaccines
Lin, D., Zeng, D., Gu, Y., Fleming, T., Krause, P.
10.1101/2021.12.22.21268201 — Posted: 2021-12-27
Antibody therapy reverses biological signatures of COVID-19 progression
Maher, M. C., Soriaga, L. B., Gupta, A., di Iulio, J., Ledoux, S., Smithey, M. J., Cathcart, A. L., McKusick, K., Sun, D., Aldinger, M., Alexander, E., Purcell, L., Ding, X., Peppercorn, A. F., Austin, D. J., Mogalian, E., Yeh, W. W., Shapiro, A. E., Corti, D., Virgin, H. W., Pang, P. S., Telenti, A.
10.1101/2021.12.21.21268197 — Posted: 2021-12-27
Controlling the worldwide chaotic spreading of COVID-19 through vaccinations
Bonasera, A., zheng, h.
10.1101/2021.12.23.21268184 — Posted: 2021-12-27
Transmission of SARS-CoV-2 among children and staff in German daycare centers: results from the COALA study
Loss, J., Wurm, J., Varnaccia, G., Schienkiewitz, A., Iwanowski, H., Loer, A.-K., Allen, J., Wess, B., Schaffrath Rosario, A., Damerow, S., Kuttig, T., Perlitz, H., Hornbacher, A., Finkel, B., Krause, C., Wormsbaecher, J., Sandoni, A., Kubisch, U., Eggers, K., Nitsche, A., Radonic, A., Trappe, K., Drechsel, O., Klaper, K., Franke, A., Huether, A., Buchholz, U., Haas, W., Wieler, L. H., Jordan, S.
10.1101/2021.12.21.21268157 — Posted: 2021-12-27
Risk of Myopericarditis following COVID-19 mRNA vaccination in a Large Integrated Health System: A Comparison of Completeness and Timeliness of Two Methods
Sharff, K., Dancoes, D. M., Longueil, J. L., Johnson, E. S., Lewis, P. F.
10.1101/2021.12.21.21268209 — Posted: 2021-12-27 Discussion: Onsite
Home Monitoring for Fever: An Inexpensive Screening Method to Prevent Household Spread of COVID-19
Kim, J., Threadcraft, M. A., Xue, W., Yue, S., Wenzel, R. P., Southwick, F. S.
10.1101/2021.12.21.21268203 — Posted: 2021-12-27
Interpretable and Predictive Deep Modeling of the SARS-CoV-2 Spike Protein Sequence
Sokhansanj, B. A., Zhao, Z., Rosen, G. L.
10.1101/2021.12.26.21268414 — Posted: 2021-12-27
Cooccurrence of N501Y, P681R and other key mutations in SARS-CoV-2 Spike
Lee, C., Mangalaganesh, S., Wilson, L. O., Kuiper, M. J., Drew, T. W., Vasan, S. S.
10.1101/2021.12.25.21268404 — Posted: 2021-12-27
Disease severity related to VOC dominance in unvaccinated SARS-CoV-2 positive adults without risk factors in Sweden
Wahlstrom, E., Bruce, D., Bennet-Bark, A. M., Walther, S., Hanberger, H., Stralin, K.
10.1101/2021.12.23.21268040 — Posted: 2021-12-27
Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine?
Ogura, W., Ohtsuka, K., Matsuura, S., Okuyama, T., Matsushima, S., Yamasaki, S., Miyagi, H., Sekiguchi, K., Ohnishi, H., Watanabe, T.
10.1101/2021.12.26.21268358 — Posted: 2021-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).